Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme
Journal of Oncology Pharmacy Practice, cilt.23, sa.5, ss.392-395, 2017 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 23 Sayı: 5
- Basım Tarihi: 2017
- Doi Numarası: 10.1177/1078155216643858
- Dergi Adı: Journal of Oncology Pharmacy Practice
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.392-395
- Anahtar Kelimeler: Bevacizumab, bleeding, recurrent glioblastome multiforme
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Bevacizumab is a humanized monoclonal antibody targeting vascular endothelial growth factor, and it has been shown to improve progression-free survival in patients with recurrent glioblastome multiforme when administered as second-line therapy. However, it has been associated with serious and fatal hemorrhagic events. Here, we present a 68-year-old male who developed severe periocular bleeding while on bevacizumab for recurrent temozolamide-resistant glioblastome multiforme.